Dr. Kejal Kantarci, MD
Claim this profileStudies Lewy Body Dementia
Studies Exacerbation
1 reported clinical trial
1 drug studied
More about Kejal Kantarci, MD
Clinical Trial Related6 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Kejal Kantarci, MD has experience with
- 18F-Flortaucipir
Breakdown of trials Kejal Kantarci, MD has run
Lewy Body Dementia
Exacerbation
Lewy Body Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kejal Kantarci, MD specialize in?
Kejal Kantarci, MD focuses on Lewy Body Dementia and Exacerbation. In particular, much of their work with Lewy Body Dementia has involved treating patients, or patients who are undergoing treatment.
Is Kejal Kantarci, MD currently recruiting for clinical trials?
No, Kejal Kantarci, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Kejal Kantarci, MD has studied deeply?
Yes, Kejal Kantarci, MD has studied treatments such as 18F-Flortaucipir.
What is the best way to schedule an appointment with Kejal Kantarci, MD?
Apply for one of the trials that Kejal Kantarci, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.